Literature DB >> 29948493

Effect of Synadenium grantii and its isolated compound on dysmenorrhea behavior model in mice.

Flávia Werner da Rocha Jesuíno1, Jaqueline Pavesi Reis2, Juliana Cristina Pereira Whitaker3, Adriana Campos1, Maria Verônica Dávila Pastor2, Valdir Cechinel Filho1,4, Nara Lins Meira Quintão5.   

Abstract

OBJECTIVE: This study aimed to evaluate the effects of the methanol extract of Synadenium grantii Hook f. stems and its main isolated compound Query3,4,12,13-tetraacetylforbol-20-phenylacetate (1) on experimental dysmenorrhea in mice.
METHODS: Female Swiss mice (n = 6-15) of 6-8 weeks old were used, selected according to the period of the estrous cycle. Animals in proestrus were treated intraperitoneally (i.p.) for 3 days with estradiol. They orally received, on the 4th day, S. grantii extract, the compound 1, ibuprofen or hyoscine butylbromide (Buscopan compound®). Then they were injected (i.p.) with oxytocin 1 h later and individually observed regarding the abdominal writhing for 45 min. The uterus was weighed, photographed and fixed in paraffin for histological analysis. KEY
FINDINGS: The extract inhibited the abdominal writhing and similar results were obtained with compound 1 and the positive control drugs Ibuprofen and hyoscine butylbromide. Reduction of uterus volume and histological inflammatory parameters, such as oedema and leukocyte infiltrate, were observed in animals treated with the extract and compound 1.
CONCLUSIONS: Our data show promising activity of the extract against dysmenorrhea, indicating important anti-inflammatory activity. Compound 1 appears to be, at least in part, the main responsible for this promising biological effect.

Entities:  

Keywords:  Euphorbia umbellata; Medicinal plants; Mice; Primary dysmenorrhea; Synadenium umbellatum; Visceral pain

Mesh:

Substances:

Year:  2018        PMID: 29948493     DOI: 10.1007/s10787-018-0501-1

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  4 in total

1.  Involvement of a neutrophil-mast cell axis in the effects of Piper malacophyllum (C. PESL) C. DC extract and its isolated compounds in a mouse model of dysmenorrhoea.

Authors:  Nara Lins Meira Quintão; Jaqueline Pavesi Reis; Larissa Benvenutti; Roberta Nunes; Fernanda Capitanio Goldoni; Manuela Somensi Cozer; Priscila de Souza; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Jessica Melato; Carlos Rafael Vaz; Juliana Cristina Pereira Whitaker; Flavia Werner Jesuíno; Mariana Couto Costa; Maria Verônica Dávila Pastor; Angela Malheiros; Christiane Meyre-Silva; José Roberto Santin
Journal:  Inflammopharmacology       Date:  2022-07-22       Impact factor: 5.093

2.  NLRP3 inflammasome inhibitor MCC950 attenuates primary dysmenorrhea in mice via the NF-κB/COX-2/PG pathway.

Authors:  Biao Tang; Dan Liu; Lingyu Chen; Yu Liu
Journal:  J Inflamm (Lond)       Date:  2020-06-24       Impact factor: 4.981

Review 3.  Integrating Lifestyle Focused Approaches into the Management of Primary Dysmenorrhea: Impact on Quality of Life.

Authors:  Orestis Tsonis; Fani Gkrozou; Zoi Barmpalia; Annamaria Makopoulou; Vassiliki Siafaka
Journal:  Int J Womens Health       Date:  2021-03-17

4.  Pelvic Pain Alters Functional Connectivity Between Anterior Cingulate Cortex and Hippocampus in Both Humans and a Rat Model.

Authors:  Wenjun Yu; Xiaoyan Wu; Yunan Chen; Zhiying Liang; Jinxiang Jiang; Afzal Misrani; Yun Su; Yigang Peng; Jian Chen; Binliang Tang; Mengyao Sun; Cheng Long; Jun Shen; Li Yang
Journal:  Front Syst Neurosci       Date:  2021-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.